Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial.
By J. Dixon, P. O’Brien, Julie Playfair, Leon Chapman, Linda M. Schachter, S. Skinner, J. Proietto, M. Bailey, Margaret L. Anderson. Journal of the American Medical Association (JAMA), 2008
1,507 citations recorded by the source corpus.
Subfields: Pharmacy, Physiology, Surgery
View Paper: https://www.semanticscholar.org/paper/9ef8759c9c0b38fccf3d75b5d914cd2a6a218991
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pharmacy
In Physiology
- F. B. Hu
- Hannele Yki-Järvinen
- P. Scherer
- D. Nathan
- Antonio Ceriello
- Amalia Gastaldelli
- Silvio E. Inzucchi
- V. Basevi
In Surgery
- P. Scherer
- R. Kahn
- D. Nathan
- F. B. Hu
- Antonio Ceriello
- Silvio E. Inzucchi
- M. S. Kirkman
- Judith Hochman
Citations in the corpus
- 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults (2013, background): “A total of 10 studies (12 articles) met the inclusion criteria, were rated as good or fair quality, and are included in the summary table (141,142,144,148,151,155,156,159,161,168, 169,172).”
- Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes (2012, neutral): “Secretagogue 15 (37) 17 (34) 18 (37) 10 (26) 1 (2)† 5 (10)”
- Standards of Medical Care in Diabetes—2012 (2011, methodology): “One RCT compared adjustable gastric banding to “best available” medical and lifestyle therapy in subjects with type 2 diabetes diagnosed less than 2 years before randomization and with BMI 30–40 kg/m(2) (204).”
- Standards of Medical Care in Diabetes—2009 (2009, methodology): “A recent randomized controlled trial compared adjustable gastric banding to “best available” medical and lifestyle therapy in subjects with type 2 diabetes diagnosed less than 2 years before randomization and BMI 30–40 kg/m(2) (97).”
- Why Does Obesity Cause Diabetes? (2022, background): “…fatty acids released from hepatic hydrolysis of plasma triglycerides, and fatty acids that spill over into the systemic circulationduringpostprandial lipolysis of triglycerides in chylomicrons) (Donnelly et al., 2005; Fabbrini et al., 2010a; Smith et al., 2020b; Ter Horst et al., 2021).”
- American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery Medical Guidelines for Clinical Practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. (2008, neutral): “[141] Dixon JB, O’Brien PE, Playfair J, et al.”